MedPath

Can the Hypertrophy of Contralateral Testis Predict the Absence of the Non-palpable Testis in the Boys Aged From 6months to 18months of Age ?

Completed
Conditions
Focus of Study
Registration Number
NCT02203318
Lead Sponsor
Yonsei University
Brief Summary

The aim of this study is to verify whether the hypertrophy of contralateral testis may predict the absence of the non-palpable testis in the boys younger than 24months of age. According to the previous studies of other countries, the large size of the contralateral testis of the nonpalpable testis has positive correlation woth the weak viability of the affected testis. We are going to evaluate this hypothesis with prospective study. 3 groups are going to be enrolled into this study ; non-palpable testis group(Group1), palpable but not normally descended testis group(group2) and control group(group3). The size of testis will be measured with Ultrasound and the length, width and the height will be measured before surgery at outpatient department. For the group 1 \& 2, the viability of the affected testis will be evaluated and compared after surgery. In addition the comparison with normal control group is also going th be conducted.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
60
Inclusion Criteria
  1. neonates or Infants who visited the out-patient clinic with nonpalpable or undescended testis.(group 1, 2) aged from 6months to 18months
  2. neonates or Infants aged from 6months to 18months with normal testis (volunteers, Group3)
Read More
Exclusion Criteria
  1. previous history of hormonal therapy.
  2. chromosomal abnormality
  3. previous history of abdomen or inguinal area surgery
  4. children diagnosed with epididymitis or orchitis
  5. twin baby
  6. infants with premature (<37 weeks) birth history
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Size of contralateral testis1 day of initial visit

The testicular size is measured 3-dimensionally with ultrasonography. The length, width and height will be measured and the volume of testis will be evaluated.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Severance Hospital, Yonsei University College of Medicine

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath